Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03938696
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
368 | (1R)-2-{[AMINO(IMINO)METHYL]AMINO}- 1-{4-[(4R)-4-(HYDROXYMETHYL)-1,3,2- DIOXABOROLAN-2-YL]PHENYL}ETHYL NICOTINATE | A | 1ZLR | 0.72 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHJ | 0.71 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHK | 0.71 | |
S91 | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z8C | 0.75 | |
S91 | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z7L | 0.75 | |
985 | (2E)-3-{3-[6-(4-methyl-1,4-diazepan- 1-yl)pyrazin-2-yl]phenyl}prop-2- enoic acid | A | 3F2A | 0.7 | |
4QB | 3-{2-ETHYL-6-[4-(QUINOXALIN-2-YLAMINO)- BENZOYLAMINO]-HEXANOYLAMINO}-4- OXO-BUTYRIC ACID | A | 1RWN | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1S1X | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LWE | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LW0 | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 2HND | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1FKP | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1S1U | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LWF | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 2HNY | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1VRT | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LWC | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1JLB | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 3HVT | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1JLF | 0.71 | |
NIO | NICOTINIC ACID | A | 1JHQ | 0.72 | |
NIO | NICOTINIC ACID | A | 1L5L | 0.72 | |
NIO | NICOTINIC ACID | A | 2F7F | 0.72 | |
NIO | NICOTINIC ACID | A | 1L5K | 0.72 | |
NIO | NICOTINIC ACID | A | 1JHY | 0.72 | |
NIO | NICOTINIC ACID | A,B | 1FSL | 0.72 | |
NIO | NICOTINIC ACID | A | 1L5M | 0.72 | |
NIO | NICOTINIC ACID | A | 1LH6 | 0.72 | |
NIO | NICOTINIC ACID | A | 1JHO | 0.72 | |
NIO | NICOTINIC ACID | A | 3CI8 | 0.72 | |
NIO | NICOTINIC ACID | A,B,C,D | 1ICU | 0.72 | |
NIO | NICOTINIC ACID | A,B,C,D,E,F, G,H | 3HRD | 0.72 | |
NIO | NICOTINIC ACID | A | 1JHA | 0.72 | |
NIO | NICOTINIC ACID | A | 1JHV | 0.72 | |
NIO | NICOTINIC ACID | A | 1L4N | 0.72 | |
NIO | NICOTINIC ACID | A | 2LH6 | 0.72 | |
NIO | NICOTINIC ACID | A | 1D0V | 0.72 | |
NIO | NICOTINIC ACID | A,B,C,D | 1ICV | 0.72 | |
NIO | NICOTINIC ACID | A,B | 1ICR | 0.72 | |
NIO | NICOTINIC ACID | A | 1JHR | 0.72 | |
PD8 | PHOSPHORYLATED DIHYDROPTEROATE | A | 1W78 | 0.74 | |
L1C | (2R,4S)-N^1^-(4-chlorophenyl)-4- (2,4-difluorophenyl)-4-hydroxy- N^2^-(2-oxo-2H-1,3'-bipyridin-6'- yl)pyrrolidine-1,2-dicarboxamide | A | 2W3I | 0.7 | |
U05 | 6,11-DIHYDRO-11-ETHYL-6-METHYL- 9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN- 5-ONE | A | 1RTH | 0.74 | |
U05 | 6,11-DIHYDRO-11-ETHYL-6-METHYL- 9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN- 5-ONE | A | 1RT3 | 0.74 | |
U05 | 6,11-DIHYDRO-11-ETHYL-6-METHYL- 9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN- 5-ONE | A | 1LW2 | 0.74 | |
PT1 | PTEROIC ACID | A,B | 1TX0 | 0.72 | |
PT1 | PTEROIC ACID | A | 1BR6 | 0.72 | |
PT1 | PTEROIC ACID | A,B | 1HWP | 0.72 | |
IHZ | 5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine- 3-carboxamide | A | 3DKO | 0.71 | |
859 | 2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN- 4-YL}AMINO)BENZAMIDE | A,B | 2NO3 | 0.74 | |
NPV | 4-[8-(3-nitrophenyl)-1,7-naphthyridin- 6-yl]benzoic acid | A,B | 2QYN | 0.73 | |
NPV | 4-[8-(3-nitrophenyl)-1,7-naphthyridin- 6-yl]benzoic acid | A,B | 2QYK | 0.73 | |
NPV | 4-[8-(3-nitrophenyl)-1,7-naphthyridin- 6-yl]benzoic acid | A | 2QYL | 0.73 | |
NIX | NALIDIXIC ACID | A,B | 2BQ2 | 0.7 | |
OQB | 4-OXO-3-[(6-{[4-(QUINOXALIN-2-YLAMINO)- BENZOYLAMINO]-METHYL}-PYRIDINE- 3-CARBONYL)-AMINO]-BUTYRIC ACID | A | 1RWW | 0.71 | |
A96 | 6-chloro-N-pyrimidin-5-yl-3-{[3- (trifluoromethyl)phenyl]amino}- 1,2-benzisoxazole-7-carboxamide | A,B | 3DTW | 0.71 | |
FOL | FOLIC ACID | A | 1PJ6 | 0.73 | |
FOL | FOLIC ACID | A,B | 1RD7 | 0.73 | |
FOL | FOLIC ACID | A,B | 1DHF | 0.73 | |
FOL | FOLIC ACID | A,B,C,D,E | 1QZF | 0.73 | |
FOL | FOLIC ACID | A | 4CD2 | 0.73 | |
FOL | FOLIC ACID | A | 1RX7 | 0.73 | |
FOL | FOLIC ACID | A | 1RX2 | 0.73 | |
FOL | FOLIC ACID | A | 1RX8 | 0.73 | |
FOL | FOLIC ACID | A | 1RA2 | 0.73 | |
FOL | FOLIC ACID | A,B | 1RE7 | 0.73 | |
FOL | FOLIC ACID | A | 7DFR | 0.73 | |
FOL | FOLIC ACID | A | 1VIF | 0.73 | |
FOL | FOLIC ACID | A,B | 1RB2 | 0.73 | |
FOL | FOLIC ACID | A | 1CD2 | 0.73 | |
FOL | FOLIC ACID | A | 2CD2 | 0.73 | |
FOL | FOLIC ACID | A,B | 1DYI | 0.73 | |
FOL | FOLIC ACID | A | 1DRF | 0.73 | |
FOL | FOLIC ACID | A,B,C,D | 3BMC | 0.73 | |
FOL | FOLIC ACID | A,B | 2D0K | 0.73 | |
FOL | FOLIC ACID | A | 1RA8 | 0.73 | |
CEI | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A,B | 2PSJ | 0.71 | |
CEI | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A | 2F8P | 0.71 | |
CEI | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A | 1S36 | 0.71 | |
24X | H,L | 2EC9 | 0.73 | ||
APT | 2-AMINO-6-[(4-CARBOXY-PHENYLAMINO)- METHYL]-4-HYDROXY-PTERIDIN-1-IUM | A,B | 1QCJ | 0.71 | |
AXD | 2-[4-({2-[(2S,5R)-2-(AMINOMETHYL)- 5-ETHYNYLPYRROLIDIN-1-YL]-2-OXOETHYL}AMINO)- 4-METHYLPIPERIDIN-1-YL]ISONICOTINIC ACID | B | 2I03 | 0.72 | |
NTM | QUINOLINIC ACID | A | 3C2O | 0.7 | |
NTM | QUINOLINIC ACID | A,B | 1QAP | 0.7 | |
NTM | QUINOLINIC ACID | A,B,C,D,E,F | 1QPQ | 0.7 | |
NTM | QUINOLINIC ACID | A,B,C | 2B7N | 0.7 | |
NNO | 6-HYDROXYISONICOTINIC ACID N-OXIDE | M,N,O,P,Q,R | 3PCK | 0.71 | |
NNO | 6-HYDROXYISONICOTINIC ACID N-OXIDE | M,N,O,P,Q,R | 3PCM | 0.71 | |
DZF | 5-DEAZAFOLIC ACID | A,B | 2DHF | 0.74 | |
DZF | 5-DEAZAFOLIC ACID | A,B | 1DYH | 0.74 | |
DZF | 5-DEAZAFOLIC ACID | A,B,C,D | 1CDE | 0.74 | |
NFL | 2-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}NICOTINIC ACID | A | 1TD7 | 0.91 |